6533b7d4fe1ef96bd126309e

RESEARCH PRODUCT

Oral propranolol and intravitreal ranibizumab for refractory serous macular detachment secondary to retinal capillary hemangioblastoma

Rosa Dolz-marcoRoberto Gallego-pinazoÁ. Cisneros LanuzaP. Hernández-martínezManuel Díaz-llopisJ.f. Arevalo

subject

medicine.medical_specialtyRetinal Neoplasmbusiness.industrymedicine.medical_treatmentRetinal detachmentGeneral MedicinePropranololmedicine.diseaseRefractoryOphthalmologyHemangioblastomaMedicineCombined Modality TherapyRanibizumabbusinessLaser coagulationmedicine.drughttps://doi.org/10.1016/j.oftale.2015.08.003